市場調查報告書
商品編碼
1429297
凝膠植入市場:現況分析與預測(2023-2030)Gel Implant Market: Current Analysis and Forecast (2023-2030) |
預計 2023 年至 2030 年凝膠植入物市場的複合年增長率約為 3.7%。 凝膠植入物市場是指涉及凝膠狀植入物的開發、製造、行銷和分銷的醫療保健和醫療器材產業領域。 這些植入物通常由凝膠狀物質製成,用於各種醫療和美容目的。 世界人口老化是人們尋求整容手術(包括真皮填充劑和其他凝膠植入物)以恢復臉部活力和體積的主要動力。 例如,根據世界衛生組織統計,到2022年,全球65歲以上人口將達到7.71億,幾乎佔世界人口的10%。 該細分市場持續成長,預計到 2050 年將達到 16%,到 □□2100 年將達到 24%。 此外,持續的技術進步,例如創新凝膠植入材料和製造流程的開發,也有助於市場成長。 此外,人們對整容手術的認識不斷提高,加上社會接受度的提高,正在鼓勵人們考慮透過凝膠植入物來增強美容效果。
市場依產品分為矽膠植體(凝膠植入物)及小熊軟糖植體。 其中,矽膠植入物市場預計將以較高的複合年增長率成長。 矽膠植入物細分市場在美容和重建手術市場(例如隆乳和重建)中尤為突出,進一步促進了該細分市場的成長。 與其他材料相比,矽膠植入物以提供更自然的外觀和感覺而聞名。 這項特性使其成為受歡迎的選擇,尤其是對於隆乳等整容手術。 矽膠植入物在尋求更持久效果的人中很受歡迎,因為它們經久耐用且設計持久。
根據應用,市場分為整容手術和重建手術。 其中,由於社會對整容手術的接受度不斷提高,整容手術領域預計將以更高的複合年增長率增長。 人們對整容手術的態度正在發生變化,恥辱感正在減少,越來越多的人正在考慮整容手術。 整容手術的技術進步,包括更安全、更精確的技術,有助於提高患者對整容手術的信任和興趣。 全球經濟的成長和可支配收入水準的上升,特別是在某些地區,使得整容手術更容易為更多人所接受。 此外,注射劑(如真皮填充劑和肉毒桿菌)等微創手術也正在迅速普及。 與傳統的外科手術相比,這些手術的恢復時間更快,相關風險更少。
根據最終用戶,市場分為醫院和專科診所。 特別是,預計醫院在預測期內將增加凝膠植入物的採用。 對美容和重建手術(包括凝膠植入物)的需求不斷增長,推動了醫院領域的成長。 醫院設備齊全,可提供廣泛的外科服務,以滿足患者的需求。 此外,醫院通常可以獲得先進的醫療技術和手術設備,這對於安全有效地進行複雜的凝膠植入手術至關重要。 醫院擁有專業的手術團隊和整形外科、骨科、重建外科等各領域專家的醫療專業人員,使其成為凝膠植入手術的理想環境。
為了更了解凝膠植入產業的市場實施情況,市場為北美(美國、加拿大、北美其他地區)、歐洲(德國、英國、法國、西班牙、義大利、歐洲其他地區)、亞洲太平洋地區(中國、日本、印度、亞太地區其他地區)及世界其他地區。 由於乳癌盛行率不斷上升以及醫療保健專業人員和一般大眾對凝膠植入物的認識不斷增強,北美凝膠植入物市場預計將繼續成長。 例如,美國癌症協會估計,2020 年和 2023 年將診斷出 2,800 例新的男性侵襲性乳癌病例。 男性終生罹患乳癌的風險約為 833 分之一。 目前美國有超過 400 萬名女性有乳癌病史。
參與市場的主要公司包括Allergan Aesthetics、Mentor Worldwide LLC.、Sientra, Inc.、Arion Laboratories、GC Aesthetics、Sebin、廣州萬和塑膠材料有限公司、POLYTECH Health &Aesthetics GmbH、HansBioMed 、Silimed、 ETC。
The gel implant market is expected to register a CAGR of approx. 3.7% over the period of 2023-2030. The gel implant market refers to the sector of the healthcare and medical device industry that involves the development, manufacturing, marketing, and distribution of gel-based implants. These implants typically consist of gel-like substances and are used for various medical and aesthetic purposes. The global aging population is a significant driver as individuals seek aesthetic procedures, including dermal fillers and other gel implants, for facial rejuvenation and volume restoration. For instance, according to WHO, In 2022, there were 771 million people aged 65+ years globally, accounting for almost 10% of the world's population. This segment has been growing at an increasing rate, and it's expected to hit 16% in 2050, and eventually 24% by 2100. Furthermore, ongoing advancements in technology, including the development of innovative gel implant materials and manufacturing processes, contribute to the growth of the market. Moreover, growing awareness about aesthetic procedures, coupled with increased societal acceptance, encourages individuals to consider gel implants for cosmetic enhancements.
Based on the product, the market has been categorized into silicone gel implant and gummy bear implants. Among them, the into silicone gel implant segment is expected to grow at a higher CAGR in the market. The silicone gel implant segment has been notable in the aesthetic and reconstructive surgery market, particularly in breast augmentation and reconstruction, have further contributed to the growth of this segment. Silicone gel implants are known for providing a more natural look and feel compared to some other materials. This characteristic makes them a popular choice, especially in aesthetic procedures like breast augmentation. Silicone gel implants are designed to be durable and have a longer lifespan, contributing to their popularity among individuals seeking longer-lasting results.
Based on the application, the market has been categorized into cosmetic surgery, reconstructive surgery. Among them, the cosmetic surgery segment is expected to grow at a higher CAGR in the market. due to increase in social acceptance of cosmetic procedures. Attitudes towards these procedures have evolved, reducing stigma and encouraging more individuals to consider cosmetic surgery. Technological advancements in cosmetic surgery procedures, including safer and more precise techniques, have contributed to increased patient confidence and interest in these procedures. The growth of the global economy and increasing disposable income levels, especially in certain regions, has made cosmetic surgery more accessible to a broader demographic. Moreover, the popularity of minimally invasive procedures, such as injectables (e.g., dermal fillers and Botox), has surged. These procedures offer quicker recovery times and fewer associated risks compared to traditional surgical interventions.
Based on the end-user, the market has been categorized into hospitals and specialty clinics. Among them, the hospital category is to witness higher adoption of gel implants during the forecast period. The rising demand for aesthetic and reconstructive procedures, including those involving gel implants, contributes to the growth of the hospital segment. Hospitals are well-equipped to offer a wide range of surgical services to meet patient needs. In addition, hospitals often have access to advanced medical technologies and surgical equipment, which is crucial for performing complex gel implant surgeries safely and efficiently. Hospitals house specialized surgical teams and healthcare professionals with expertise in various fields, including plastic surgery, orthopedics, and reconstructive surgery, making them suitable environments for gel implant procedures.
For a better understanding of the market adoption of the gel implant industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. The North America gel implants market is expected to continue to grow in the coming years, driven by the increasing prevalence of breast cancer and growing awareness of gel implants among healthcare professionals and the general population. For instance, in 2020, according to American Cancer Society, In 2023, an estimated 2,800 new cases of invasive breast cancer are expected to be diagnosed in men. A man's lifetime risk of breast cancer is about 1 in 833. There are currently more than four million women with a history of breast cancer in the United States.
Some of the major players operating in the market include Allergan Aesthetics, Mentor Worldwide LLC., Sientra, Inc, Arion Laboratories, GC Aesthetics, Sebbin, Guangzhou Wanhe Plastic Material Co., Ltd, POLYTECH Health & Aesthetics GmbH, HansBioMed, Silimed.